NeuroOne Medical Technologies Corp. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1281739,
    "name": "NeuroOne Medical Technologies Corp.",
    "stock_name": "NeuroOne Medical Technologies Corp.",
    "full_name": "NeuroOne Medical Technologies Corp.",
    "name_url": "stocks-analysis/neuroone-medical-technologies-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.67",
    "chg": 0.01,
    "chgp": "1.31%",
    "dir": 1,
    "prev_price": "0.66",
    "mcapval": "42.50",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US64130M2098",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "142.81 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuroone-medical-technologies-corp-1281739-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is NeuroOne Medical Technologies Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-neuroone-medical-technologies-corp-technically-bullish-or-bearish-3546553",
        "imagepath": "",
        "date": "2025-09-20 19:35:34",
        "description": "As of 8 September 2025, the technical trend for NeuroOne Medical Technologies Corp. has changed from sideways to mildly bullish. The weekly MACD and KST are both bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate bullish conditions on both weekly and monthly time frames. However, daily moving averages are mildly bearish, and there are no signals from the RSI or trends noted in Dow Theory. The stock has shown a 1-month return of 8.42%, outperforming the S&P 500's 2.33% return, but has underperformed over longer periods, including a 1-year return of 4.76% compared to the S&P 500's 17.14%. Overall, the current stance is mildly bullish, supported by several indicators, despite some mixed signals in shorter time frames...."
      },
      {
        "title": "Is NeuroOne Medical Technologies Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-neuroone-medical-technologies-corp-overvalued-or-undervalued-3543106",
        "imagepath": "",
        "date": "2025-09-20 18:10:47",
        "description": "As of 22 December 2022, the valuation grade for NeuroOne Medical Technologies Corp. moved from does not qualify to risky. The company appears to be overvalued given its high price-to-book value of 25.74 and negative EV to EBITDA of -4.39, indicating significant challenges in generating earnings relative to its enterprise value. Additionally, the return on equity (ROE) is alarmingly low at -626.73%, reflecting poor profitability and financial health.\n\nIn comparison to its peers, NeuroOne's valuation ratios are concerning; for instance, LENSAR, Inc. has a worse EV to EBITDA of -12.34, while Singular Genomics Systems, Inc. shows a more favorable EV to EBITDA of 0.55. The stock's recent performance has lagged behind the S&P 500, with a year-to-date return of 8.96% compared to the S&P's 12.22%, suggesting that investors may be better served by looking elsewhere in the market...."
      }
    ],
    "total": 6,
    "sid": "1281739",
    "stock_news_url": "https://www.marketsmojo.com/news/neuroone-medical-technologies-corp-1281739"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is NeuroOne Medical Technologies Corp. technically bullish or bearish?

2025-09-20 19:35:34

As of 8 September 2025, the technical trend for NeuroOne Medical Technologies Corp. has changed from sideways to mildly bullish. The weekly MACD and KST are both bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate bullish conditions on both weekly and monthly time frames. However, daily moving averages are mildly bearish, and there are no signals from the RSI or trends noted in Dow Theory. The stock has shown a 1-month return of 8.42%, outperforming the S&P 500's 2.33% return, but has underperformed over longer periods, including a 1-year return of 4.76% compared to the S&P 500's 17.14%. Overall, the current stance is mildly bullish, supported by several indicators, despite some mixed signals in shorter time frames....

Is NeuroOne Medical Technologies Corp. overvalued or undervalued?

2025-09-20 18:10:47

As of 22 December 2022, the valuation grade for NeuroOne Medical Technologies Corp. moved from does not qualify to risky. The company appears to be overvalued given its high price-to-book value of 25.74 and negative EV to EBITDA of -4.39, indicating significant challenges in generating earnings relative to its enterprise value. Additionally, the return on equity (ROE) is alarmingly low at -626.73%, reflecting poor profitability and financial health. In comparison to its peers, NeuroOne's valuation ratios are concerning; for instance, LENSAR, Inc. has a worse EV to EBITDA of -12.34, while Singular Genomics Systems, Inc. shows a more favorable EV to EBITDA of 0.55. The stock's recent performance has lagged behind the S&P 500, with a year-to-date return of 8.96% compared to the S&P's 12.22%, suggesting that investors may be better served by looking elsewhere in the market....

View All News